Medicare FFS ophthalmology
Provider service volume comparison
Compare two ophthalmology providers by CY2023 Medicare FFS service volume and CPT/HCPCS mix.
Jason E Ysasaga, M.D.
NPI 1356310734 | Amarillo, TX
- National rank
- #15
- Total services
- 205,514
Choose provider
No provider selected.
Search providersCPT/HCPCS service volume comparison
Rows compare visible public provider-service lines by Medicare FFS service count.
| CPT/HCPCS | Description | Provider A services | Provider B services | Absolute difference | Higher Medicare FFS service volume |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 165,855 | 0 | 165,855 | Provider A higher |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 5,535 | 0 | 5,535 | Provider A higher |
| 67028 | Injection of drug into eye | 5,018 | 0 | 5,018 | Provider A higher |
| 92134 | Imaging of retina | 4,878 | 0 | 4,878 | Provider A higher |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 4,611 | 0 | 4,611 | Provider A higher |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 4,042 | 0 | 4,042 | Provider A higher |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 2,882 | 0 | 2,882 | Provider A higher |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 1,855 | 0 | 1,855 | Provider A higher |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 1,843 | 0 | 1,843 | Provider A higher |
| 92240 | Exam of blood vessels between the white part of eye and retina using a special camera after injection of a dye | 1,512 | 0 | 1,512 | Provider A higher |
| J3490 | Unclassified drugs | 986 | 0 | 986 | Provider A higher |
| J2778 | Injection, ranibizumab, 0.1 mg | 825 | 0 | 825 | Provider A higher |
| 92250 | Photography of the retina | 824 | 0 | 824 | Provider A higher |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 497 | 0 | 497 | Provider A higher |
| 92242 | Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye | 452 | 0 | 452 | Provider A higher |
| 67210 | Destruction of growth of retina using a laser | 208 | 0 | 208 | Provider A higher |
| 67228 | Destruction of leaking blood vessels of retina using laser | 170 | 0 | 170 | Provider A higher |
| J7999 | Compounded drug, not otherwise classified | 131 | 0 | 131 | Provider A higher |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | 127 | 0 | 127 | Provider A higher |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 102 | 0 | 102 | Provider A higher |
| 76512 | 2d ultrasound scan of eye tissue and structures | 100 | 0 | 100 | Provider A higher |
| J0178 | Injection, aflibercept, 1 mg | 92 | 0 | 92 | Provider A higher |
| 92014 | Established patient complete exam of visual system | 84 | 0 | 84 | Provider A higher |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | 74 | 0 | 74 | Provider A higher |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 64 | 0 | 64 | Provider A higher |
| 67041 | Removal of membrane of retina | 62 | 0 | 62 | Provider A higher |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | 35 | 0 | 35 | Provider A higher |
| 66821 | Removal of recurring cataract in lens capsule using a laser | 34 | 0 | 34 | Provider A higher |
| J9035 | Injection, bevacizumab, 10 mg | 32 | 0 | 32 | Provider A higher |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 18 | 0 | 18 | Provider A higher |
| 67515 | Injection of drug or substance into membrane covering eyeball | 16 | 0 | 16 | Provider A higher |
| 67145 | Photocoagulation treatment to prevent detachment of retina | 13 | 0 | 13 | Provider A higher |
| 76510 | 1d and 2d ultrasound scan of eye tissue and structures | 12 | 0 | 12 | Provider A higher |